Charles Schwab Investment Management Inc Guardant Health, Inc. Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Guardant Health, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 996,506 shares of GH stock, worth $44.3 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
996,506
Previous 1,016,533
1.97%
Holding current value
$44.3 Million
Previous $31.1 Million
36.7%
% of portfolio
0.01%
Previous 0.01%
Shares
26 transactions
Others Institutions Holding GH
# of Institutions
394Shares Held
121MCall Options Held
1.43MPut Options Held
2.37M-
Vanguard Group Inc Valley Forge, PA12.1MShares$537 Million0.01% of portfolio
-
Black Rock Inc. New York, NY11.2MShares$499 Million0.01% of portfolio
-
Deep Track Capital, LP Greenwich, CT5.44MShares$242 Million8.11% of portfolio
-
Capital International Investors Los Angeles, CA5.15MShares$229 Million0.04% of portfolio
-
Baillie Gifford & CO5.06MShares$225 Million0.19% of portfolio
About Guardant Health, Inc.
- Ticker GH
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 102,220,000
- Market Cap $4.54B
- Description
- Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...